Delivery Order SPE2DB22D1106-SPE2DB24FFBM0

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.36 firm fixed price delivery order covers the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. This award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,150.76 Firm Fixed Price Delivery Order covers the supply of Quillivant XR 25 mg/5 ml suspension medication with a completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.74 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,409.08 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a completion date of September 27, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,744.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract is a Firm Fixed Price Delivery Order with a completion date of September 12, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medical commodities, including prescription...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a Firm Fixed Price Delivery Order for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,713.92 Firm Fixed Price Delivery Order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a completion date of June 14, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,467.94 firm fixed price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a 60 ml pharmaceutical product. The contract has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp, as the prime contractor, does not have a set-aside designation for this award....
This federal contract award, valued at $1,552.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract...
This federal contract award, valued at $2,805.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a 150 ml prescription medication. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFBM0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,579.48 Firm Fixed Price Delivery Order is for the supply of Quillivant XR, a 25 mg/5 ml suspension medication, with a period of performance through July 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation, reflecting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 10/10/24, 9:03 AM